Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543748 | NSE Symbol : AARTIPHARM | ISIN : INE0LRU01027 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
28-Jan-2025	05-Feb-2025	Quarterly Results	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve 1. Audited Financial Results of the Company for the quarter and nine-months ended December 31 2024 after these results are reviewed by the Audit Committee of the Board. 2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2024-25. Financial Results For Quarter Ended December 31, 2024 (As per BSE Announcement Dated on 05/02/2025)
13-Dec-2024	13-Dec-2024	Change in Other Executives	Appointment of Company Secretary and Compliance officer w.e.f. December 13, 2024
21-Oct-2024	28-Oct-2024	Half Yearly Results	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve 1. Audited Financial Results for the quarter and half year ended September 30 2024; 2. Any other business matter if required with the permission of Chair. Financial Results for the quarter and Half year ended September 30, 2024 (As Per BSE Announcement dated on 28.10.2024)
29-Jul-2024	05-Aug-2024	Accounts	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve Audited Financial Results for the quarter ended June 30 2024 and any other business matter if required with the permission of Chair. Outcome of the Board Meeting Financial Results for the Quarter ended June 30, 2024 (As per BSE Announcement Dated on 05/08/2024)
04-May-2024	13-May-2024	Quarterly Results	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve Audited Financial Results for the quarter ended March 31 2024; Audited Financial Statements for the year ended March 31 2024; Recommend Final Dividend if any for the year ended March 31 2024; Approve any other business matter if required with the permission of Chair. Outcome of Board Meeting Appointment of Auditors (As Per BSE Announcement dated on 13.05.2024)
30-Jan-2024	07-Feb-2024	Interim Dividend	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve Audited Financial Results for the quarter and nine months ended December 31 2023 Interim Dividend if any for the FY 2023-24 and other business matters if any. Interim Dividend for FY 2023-24 Financial results and Interim dividend Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023 Record date for Interim dividend (As Per BSE Announcement Dated on 07.02.2024)
30-Oct-2023	07-Nov-2023	Accounts	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve Audited Financial Results for the quarter and half year ended September 30 2023 and Any other business matter if any Financial Results for the quarter and half year ended September 30, 2023 (As per BSE Announcement Dated on 07/11/2023)
28-Jul-2023	05-Aug-2023	Quarterly Results	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve Audited Financial Results and any other Business Matter if required. Outcome of the Board Meeting held on Saturday, August 05, 2023. (As Per BSE Announcement Dated on 05.08.2023)
03-May-2023	12-May-2023	Quarterly Results	Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2023 inter alia to consider and approve - Audited Financial Results for the quarter ended March 31 2023 and Audited Financial Statements for the year ended March 31 2023 - Any other business matter if required with the permission of Chair Outcome of Board Meeting held on May 12,2023 Audited Financial Results (Standalone and Consolidated) for Quarter and Year Ended March 31, 2023. (As per BSE Announcement Dated on 12/05/2023)
13-Feb-2023	17-Jan-2023	Quarterly Results	Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. Financial Statements for the nine months ended December 31, 2022 (As Per BSE Announcement Dated on 14.02.2023)

LOGIN HERE

Aarti Pharmalabs Ltd

Board Meeting